[go: up one dir, main page]

WO2000026244A3 - A novel tumor necrosis factor family member, drl, and related compositions and methods - Google Patents

A novel tumor necrosis factor family member, drl, and related compositions and methods Download PDF

Info

Publication number
WO2000026244A3
WO2000026244A3 PCT/US1999/025954 US9925954W WO0026244A3 WO 2000026244 A3 WO2000026244 A3 WO 2000026244A3 US 9925954 W US9925954 W US 9925954W WO 0026244 A3 WO0026244 A3 WO 0026244A3
Authority
WO
WIPO (PCT)
Prior art keywords
drl
seq
set forth
provides
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/025954
Other languages
French (fr)
Other versions
WO2000026244A2 (en
Inventor
Michael J Lenardo
Jin Wang
Di Jiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Priority to AU14670/00A priority Critical patent/AU1467000A/en
Publication of WO2000026244A2 publication Critical patent/WO2000026244A2/en
Publication of WO2000026244A3 publication Critical patent/WO2000026244A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides an isolated nucleic acids encoding DRL proteins, DRL-1 and DRL-2, as set forth in the Sequence Listing as SEQ ID NO:1 and SEQ ID NO:3, respectively. The invention also provides a unique fragment of SEQ ID NO:1 that encodes amino acid residues 65 to 250 of DRL-1 as set forth in SEQ ID NO:2. The invention further provides purified polypeptides encoded by the nucleic acids encoding the DRL proteins as set forth in SEQ ID NO:1 and SEQ ID NO:3, purified polypeptide having the sequences set forth in the sequence listing as SEQ ID NO:2, SEQ ID NO:4 and SEQ ID NO:6 and of DRL polypeptides which can be used to stimulate an immune response or induce apoptosis. In another aspect the invention provides purified antibodies which bind to the DRL protein or fragments thereof. These antibodies can be used to inhibit a T cell response, to inhibit apoptosis or to suppress an autoimmune response.
PCT/US1999/025954 1998-11-04 1999-11-04 A novel tumor necrosis factor family member, drl, and related compositions and methods Ceased WO2000026244A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU14670/00A AU1467000A (en) 1998-11-04 1999-11-04 A novel tumor necrosis factor family member, drl, and related compositions and methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10697698P 1998-11-04 1998-11-04
US60/106,976 1998-11-04

Publications (2)

Publication Number Publication Date
WO2000026244A2 WO2000026244A2 (en) 2000-05-11
WO2000026244A3 true WO2000026244A3 (en) 2000-11-09

Family

ID=22314220

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/025954 Ceased WO2000026244A2 (en) 1998-11-04 1999-11-04 A novel tumor necrosis factor family member, drl, and related compositions and methods

Country Status (2)

Country Link
AU (1) AU1467000A (en)
WO (1) WO2000026244A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7217788B2 (en) 1996-03-14 2007-05-15 Human Genome Sciences, Inc. Human tumor necrosis factor delta polypeptides
US6541224B2 (en) 1996-03-14 2003-04-01 Human Genome Sciences, Inc. Tumor necrosis factor delta polypeptides
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US6689579B1 (en) 1996-10-25 2004-02-10 Human Genome Sciences, Inc. Polynucleotides encoding neutrokine-α
US20030095967A1 (en) 1999-01-25 2003-05-22 Mackay Fabienne BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
CA2360062A1 (en) 1999-01-25 2000-07-27 Biogen, Inc. Baff, inhibitors thereof and their use in the modulation of b-cell response
EP1210425B2 (en) 1999-08-17 2015-06-17 Biogen MA Inc. Baff receptor (bcma), an immunoregulatory agent
UA74798C2 (en) 1999-10-06 2006-02-15 Байоджен Айдек Ма Інк. Method for treating cancer in mammals using polypeptide interfering with interaction between april and its receptors
EP2275449B1 (en) 2000-06-16 2016-09-28 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to BLyS
US7220840B2 (en) 2000-06-16 2007-05-22 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to B lymphocyte stimulator protein
US20030091565A1 (en) 2000-08-18 2003-05-15 Beltzer James P. Binding polypeptides and methods based thereon
DE10045591A1 (en) * 2000-09-15 2002-04-04 Klaus Pfizenmaier Site-specific, antibody-mediated activation of proapoptotic cytokines - AMAIZe (Antibody-Mediated Apoptosis Inducing Cytokines)
UA83458C2 (en) 2000-09-18 2008-07-25 Байоджен Айдек Ма Інк. The isolated polypeptide baff-r (the receptor of the factor of activation of b-cells of the family tnf)
JP2004537290A (en) 2001-05-24 2004-12-16 ヒューマン　ジノーム　サイエンシーズ，　インコーポレイテッド Antibodies to tumor necrosis factor δ (APRIL)
AU2004233164B2 (en) 2003-03-28 2009-10-08 Biogen Ma Inc. Truncated BAFF receptors
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
WO2006044582A2 (en) 2004-10-13 2006-04-27 The Washington University Use of baff to treat sepsis
US9168286B2 (en) 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
CA2629306A1 (en) 2005-11-23 2007-05-31 Genentech, Inc. Methods and compositions related to b cell assays
US8211649B2 (en) 2006-03-31 2012-07-03 Human Genome Sciences, Inc. Methods of diagnosing and prognosing hodgkin's lymphoma
TW202309043A (en) * 2021-04-16 2023-03-01 奧地利商納畢瓦治療有限責任公司 Novel 12-epi-mutilin compounds and uses thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994019463A2 (en) * 1993-02-16 1994-09-01 Auckland Uniservices Limited Developmental tyrosine kinases and their ligands
WO1997033902A1 (en) * 1996-03-14 1997-09-18 Human Genome Sciences, Inc. Human tumor necrosis factor delta and epsilon
EP0869180A1 (en) * 1997-04-02 1998-10-07 Smithkline Beecham Corporation A TNF homologue, TL5
WO1998055621A1 (en) * 1997-06-06 1998-12-10 Regeneron Pharmaceuticals, Inc. Ntn-2 member of tnf ligand family
WO1998055620A1 (en) * 1997-06-06 1998-12-10 Regeneron Pharmaceuticals, Inc. Ntn-2 member of tnf ligand family
WO1999011791A2 (en) * 1997-09-05 1999-03-11 University Of Washington Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
EP0919620A2 (en) * 1997-11-26 1999-06-02 Eli Lilly And Company TRAILLK-3: a member of the TNF ligand family
WO1999028462A2 (en) * 1997-12-03 1999-06-10 Genentech, Inc. Polypeptides and nucleic acids encoding the same

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994019463A2 (en) * 1993-02-16 1994-09-01 Auckland Uniservices Limited Developmental tyrosine kinases and their ligands
WO1997033902A1 (en) * 1996-03-14 1997-09-18 Human Genome Sciences, Inc. Human tumor necrosis factor delta and epsilon
EP0869180A1 (en) * 1997-04-02 1998-10-07 Smithkline Beecham Corporation A TNF homologue, TL5
WO1998055621A1 (en) * 1997-06-06 1998-12-10 Regeneron Pharmaceuticals, Inc. Ntn-2 member of tnf ligand family
WO1998055620A1 (en) * 1997-06-06 1998-12-10 Regeneron Pharmaceuticals, Inc. Ntn-2 member of tnf ligand family
WO1999011791A2 (en) * 1997-09-05 1999-03-11 University Of Washington Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents
EP0919620A2 (en) * 1997-11-26 1999-06-02 Eli Lilly And Company TRAILLK-3: a member of the TNF ligand family
WO1999028462A2 (en) * 1997-12-03 1999-06-10 Genentech, Inc. Polypeptides and nucleic acids encoding the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HAHNE M ET AL: "APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth", JOURNAL OF EXPERIMENTAL MEDICINE,JP,TOKYO, vol. 188, no. 6, 21 September 1998 (1998-09-21), pages 1185 - 1190-1190, XP002099001, ISSN: 0022-1007 *

Also Published As

Publication number Publication date
AU1467000A (en) 2000-05-22
WO2000026244A2 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
WO2000026244A3 (en) A novel tumor necrosis factor family member, drl, and related compositions and methods
WO1999055868A3 (en) Fizz proteins
Choi-Miura et al. Identification of the disulfide bonds in human plasma protein SP-40, 40 (apolipoprotein-J)
BG102983A (en) Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application
WO2001055364A8 (en) Nucleic acids, proteins, and antibodies
WO1999060127A3 (en) Il-17 homologous polypeptides and therapeutic uses thereof
WO2002016418A3 (en) An iap binding peptide or polypeptide and methods of using the same
EP2327775A3 (en) Therapy for alpha-galactosidase a deficiency
AU4778101A (en) Novel polypeptides, and nucleic acids encoding the same
CA2337100A1 (en) Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same
WO2000066156A8 (en) Death domain containing receptor 5
WO2002008426A3 (en) Fh-binding protein of streptococcus pneumoniae
HK1039783A1 (en) Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses
WO2002068459A3 (en) Non aggregating fluorescent proteins and methods for using the same
WO2000039297A3 (en) Il-1 related polypeptides
WO2000059942A3 (en) Human obesity protein binding protrein-2 homolog and uses thereof
WO2001070978A3 (en) Polypeptides and nucleic acids encoding same
WO2001062928A3 (en) Polypeptides and nucleic acids encoding same
EP0342173A3 (en) Fibronectin binding protein as well as its preparation
CA2374513A1 (en) Il-1 eta dna and polypeptides
WO2001036638A8 (en) Polypeptides and nucleic acids encoding same
Tanaka et al. Amino acid sequence of troponin-I from Akazara scallop striated adductor muscle
WO2000043419A3 (en) Exocytosis pathway proteins and methods of use
CA2642146A1 (en) Xrec2 dnas and polypeptides
WO2001068851A3 (en) Polypeptides and nucleic acids encoding same

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref country code: AU

Ref document number: 2000 14670

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase